Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising number of government initiatives and recommendations
3.2.1.2 High R&D investments in clinical research and life sciences research
3.2.1.3 Increasing production of new biologics due to high disease burden
3.2.2 Industry pitfalls & challenges
3.2.2.1 Time-consuming approval process
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product and Services, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Consumables
5.3 Instruments
5.4 Services
5.5 Reagents and kits
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Vaccine and therapeutics
6.2.1 Vaccines
6.2.2 Monoclonal antibodies
6.2.3 Recombinant protein
6.3 Blood and blood-based products
6.4 Gene therapy
6.5 Tissue and tissue-based products
6.6 Stem cells
Chapter 7 Market Estimates and Forecast, By Test Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Endotoxin tests
7.3 Sterility tests
7.4 Mycoplasma tests
7.5 Bioburden tests
7.6 Residual host-cell proteins and DNA detection tests
7.7 Virus safety tests
7.8 Adventitious agent detection tests
7.9 Other test types
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Argentina
8.5.3 Mexico
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 bioMerieux S.A.
9.2 Charles River Laboratories International, Inc.
9.3 Eurofins Scientific SE
9.4 F. Hoffmann-La Roche Ltd
9.5 Lonza Group Ltd
9.6 Merck KGaA
9.7 Samsung Biologics.
9.8 Sartorius AG
9.9 SGS Societe Generale de Surveillance SA
9.10 Thermo Fisher Scientific Inc.
